Jiangxi Favors Local Unique, New, First-Generic Drugs For Regional EDL
This article was originally published in PharmAsia News
Executive Summary
Jiangxi Province recently requested local pharmaceutical companies to apply for their drugs to become regional EDL entries, especially those new, unique in variety or dosage or first-to-market generics.